← FDA Drug Approvals (Drugs@FDA)
BALZIVA-21
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: BARR · Approved 2004-04-22
Drug application
- FDA Application #
ANDA076198- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- BALZIVA-21
- Generic name
- Ethinyl Estradiol
- Active ingredients
- ETHINYL ESTRADIOL; NORETHINDRONE
- Dosage form
- TABLET
- Route
- ORAL-21
- Marketing status
- Discontinued
- Sponsor
- BARR
- First approval
- 2004-04-22
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown